These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11201860)

  • 1. Moisture chamber for management of corneal ulcer due to Graves' ophthalmopathy.
    Akamizu T; Kaneko H; Noguchi N; Kashii S; Nakao K
    Thyroid; 2000 Dec; 10(12):1123-4. PubMed ID: 11201860
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgical palliation of ophthalmopathy of Graves' disease. Transantral approach.
    DeSanto LW
    Mayo Clin Proc; 1972 Dec; 47(12):989-92. PubMed ID: 4117993
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined cyclosporin-A and methylprednisolone treatment of Graves' ophthalmopathy.
    Leövey A; Bakó G; Szabó J; Kálmán K; Fórizs E
    Acta Med Hung; 1992-1993; 49(3-4):179-85. PubMed ID: 1345455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmopathy in childhood Graves' disease.
    Chan W; Wong GW; Fan DS; Cheng AC; Lam DS; Ng JS
    Br J Ophthalmol; 2002 Jul; 86(7):740-2. PubMed ID: 12084741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracentral corneal dellen: a rare sign of Graves ophthalmopathy.
    Yan J; Wu Z
    Yan Ke Xue Bao; 2003 Sep; 19(3):174-5. PubMed ID: 14574976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylprednisolone increases plasma leptin levels in Graves' hyperthyroidism patients with active Graves' ophthalmopathy.
    Song YM; Lee WJ; Chen MD; Kao CH; Sheu WH
    Horm Metab Res; 2000 Jul; 32(7):277-82. PubMed ID: 10965934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
    Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I
    Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal ulcer caused by Pasteurella multocida.
    Purcell JJ; Krachmer JH
    Am J Ophthalmol; 1977 Apr; 83(4):540-2. PubMed ID: 577379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
    Brauer VF; Scholz GH
    Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.
    Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous methylprednisolone pulse therapy in the treatment of Graves' ophthalmopathy.
    Matejka G; Vergès B; Vaillant G; Petit JM; Brun-Pacaud A; Rudoni S; Brun JM
    Horm Metab Res; 1998 Feb; 30(2):93-8. PubMed ID: 9543692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Steroid therapy for Graves' ophthalmopathy].
    Hiromatsu Y
    Nihon Rinsho; 2006 Dec; 64(12):2279-85. PubMed ID: 17154092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.
    Bartalena L; Marcocci C; Chiovato L; Laddaga M; Lepri G; Andreani D; Cavallacci G; Baschieri L; Pinchera A
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1139-44. PubMed ID: 6341388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy.
    Fatourechi V; Bartley GB; Eghbali-Fatourechi GZ; Powell CC; Ahmed DD; Garrity JA
    Thyroid; 2003 Dec; 13(12):1141-4. PubMed ID: 14751035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the patients with Grave's ophthalmopathy after the corticosteroids treatment.
    Petrović MJ; Sarenac T; Srećković S; Petrović M; Vulović D; Janićijević K
    Vojnosanit Pregl; 2012 Mar; 69(3):249-52. PubMed ID: 22624411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular myasthenia gravis associated with euthyroid ophthalmopathy.
    Kusuhara T; Nakajima M; Imamura A
    Muscle Nerve; 2003 Dec; 28(6):764-6. PubMed ID: 14639594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of patients and choice of operation for orbital decompression in graves ophthalmopathy.
    DeSanto LW; Gorman CA
    Laryngoscope; 1973 Jun; 83(6):945-59. PubMed ID: 4740248
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy with large doses of methylprednisolone in Basedow's ophthalmopathy].
    Zbranca E; Mogoş V; Nisfoeanu G; Vulpoi C; Gneazdovschi V; Georgescu D
    Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):151-3. PubMed ID: 9524673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.